Bremworth (BRW) H2 2025 earnings summary

Executive summary

• FY25 revenue reached $88.9 million, up from $80.3 million year-over-year.

• Net profit after tax was $18.2 million, including one-off items such as insurance claims and restructuring costs.

• Normalised EBITDA loss widened to $13.2 million from a $4.7 million loss in FY24.

• Challenging trading conditions and supply chain disruptions impacted performance.

Financial highlights

• Gross margin declined to 13.4% from 24.3% year-over-year due to market and supply chain pressures.

• Cash and bank balances at year-end were $42.2 million, boosted by insurance proceeds.

• Capital expenditure totaled $5.5 million, mainly for Napier plant reinstatement.

Outlook and guidance

• Strategic initiatives underway to restore profitability, including expanding production and reintroducing synthetics.

• Board-led strategic review of ownership structure ongoing, with no certainty of transaction.

• Update on strategic priorities to be provided at the Annual Shareholders Meeting.